Track China Health Technology Group Holding Company Limited's EBIT ($-5.7M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2025
Trailing 12 months ending Dec 31, 2025
The latest EBIT for 1069.HK is $-5.7M as of December 2025. That compares with $-64M in the prior-year period — up 91.1% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside China Health Technology Group Holding Company Limited's historical trend and sector peers before judging valuation or financial health.
Over the past year, 1069.HK's EBIT moved from $-64M to $-5.7M — a 91.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in China Health Technology Group Holding Company Limited's operating scale or balance-sheet position.
Against its sector companies, 1069.HK currently prints $-5.7M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at China Health Technology Group Holding Company Limited's growth, margins, and balance sheet.
A EBIT figure of $-5.7M for 1069.HK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.
After noting 1069.HK's EBIT ($-5.7M), review year-over-year change from $-64M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.